NCT06825091
- Conditions
- Localized Prostate Cancer, Stereotactic Body Radiotherapy
- Locations
-
- Princess Margaret Cancer Center Toronto, Ontario, Canada
Clinical trial condition
Stereotactic Body Radiotherapy
Explore clinical trials studying Stereotactic Body Radiotherapy. Study availability and eligibility vary by location and protocol.
16 public trials
4 recruiting studies
Stereotactic Body Radiotherapy trial results
NCT06542159
- Conditions
- Adaptive Radiotherapy, Bronchial Neoplasms, Carcinoma, Bronchogenic, +12 more
- Locations
-
- Sun yat-sen University Cancer Center Guangzhou, Guangdong, China
Recruiting
Safety and Efficacy of Preoperative SBRT and Radical Surgery for Soft Tissue Sarcoma of Extremities
NCT06760221
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +4 more
- Locations
-
- the second affiliated hospital of Zhejiang University Hangzhou, Zhejiang, China, 310009 Hangzhou, Zhejiang, China
NCT06595108
- Conditions
- Advanced Hepatocellular Carcinoma, Chemotherapy, Stereotactic Body Radiotherapy
- Locations
-
- Yongin Severance Hospital Yongin-si, South Korea
Not Yet Recruiting
Neoadjuvant SF-SBRT Plus Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC.
NCT07608159
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
Not specified
Not Yet Recruiting
Functional Lung Avoidance Planning Guided by Lung Perfusion PET/CT Versus Anatomical Planning for Lung Stereotactic Body Radiotherapy
NCT07289646
- Conditions
- 68Ga-MAA, Disease, Lung Cancer (Diagnosis), +10 more
- Locations
-
- CHU Brest Brest, Finistère, France
- Centre de Lutte Contre le Cancer Leon Bérard Lyon Lyon, France
Not Yet Recruiting
Stereotactic Body RadioTherapy With Continuous Tracking for Primary and Secondary Renal Cancer
NCT07285538
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +11 more
- Locations
-
- Department of Radiation Oncology, IRCCS San Raffaele Scientific Institute Milan, Milano (MI), Italy
NCT05802654
- Conditions
- Early Lung Cancer, Lung Diseases, Lung Neoplasms, +6 more
- Locations
-
- Department of radiation oncology, Peking University Third Hospital Beijing, Beijing Municipality, China
Not Yet Recruiting
Phase Ib/II Trial of Combining Pembrolizumab and Lenvatinib With SBRT for HCC Patients With Portal Vein Thrombosis.
NCT05286320
- Conditions
- Lenvatinib, Pembrolizumab, Stereotactic Body Radiotherapy, +1 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiawn, Taiwan
NCT06408753
- Conditions
- Hepatocellular Carcinoma Non-resectable, Stereotactic Body Radiotherapy
- Locations
-
- Department of Clinical Oncology Hong Kong